Leo Pharma
Clinical trials sponsored by Leo Pharma, explained in plain language.
-
New cream could ease debilitating hand and foot blisters
Disease control Recruiting nowThis study is testing whether a new cream called delgocitinib can reduce painful blisters and improve skin in adults with palmoplantar pustulosis, a chronic skin condition affecting the palms and soles. About 135 participants will apply the cream or a placebo twice daily for 16 w…
Phase: PHASE2 • Sponsor: LEO Pharma • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New shot offers hope for kids with severe, itchy skin
Disease control Recruiting nowThis trial is testing whether an injectable drug called tralokinumab, when used with standard steroid creams, is safe and effective for controlling moderate-to-severe eczema in children and infants. It involves about 195 participants, from 6 months to under 12 years old, who have…
Phase: PHASE3 • Sponsor: LEO Pharma • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC